Global Prevalence of Clinically Significant Insomnia Among Cancer Patients: A Systematic Review and Meta‐Analysis
Brain and Behavior · 2026-11 · 16 (11)
DOI: 10.1002/brb3.71857 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Brain and Behavior, online erschienen am 13.11.2026. Verfasst von Ting Du und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center of Gerontology and Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, China. Hauptthemen laut MEDLINE: Neoplasms, Sleep Initiation and Maintenance Disorders. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege, Schlaf
Abstract (Originalsprache)
Background
Clinically significant insomnia is associated with multiple adverse health outcomes in cancer patients. This study aimed to examine the global prevalence of clinically significant insomnia among cancer patients and to determine the moderators of the prevalence estimate.
Methods
Literature search was conducted from inception to October 1, 2025, across 11 major electronic databases, including PubMed, Web of Science, Scopus, Embase, PsycINFO, Cochrane Library, CINAHL, CNKI, Wanfang, VIP, and CBM. Methodological quality was evaluated using the Joanna Briggs Institute (JBI) critical appraisal tool. A random‐effects model was employed to calculate the pooled prevalence using Stata 15.0. Using the I 2 statistic to assess heterogeneity, we also conducted subgroup analyses and meta‐regression to identify its possible sources.
Results
On the basis of a total of 39 studies comprising 14,094 cancer patients, the pooled prevalence of clinically significant insomnia was 34.6% (95% CI: 27.2–44.1). A total of 25 studies were assessed as having a low overall risk of bias and 14 as having a moderate risk. Subgroup and meta‐regression analyses identified country income level and sample size as significant determinants of the pooled prevalence.
Conclusions
Our findings indicated a high global prevalence of clinically significant insomnia in cancer patients, highlighting the urgency to integrate sleep health management into routine oncology care to optimize their health outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center of Gerontology and Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Zitieren
APA
Du, T., Luo, L., Gao, L., & Lv, J. (2026). Global Prevalence of Clinically Significant Insomnia Among Cancer Patients: A Systematic Review and Meta‐Analysis. Brain and Behavior, 16(11). https://doi.org/10.1002/brb3.71857
Vancouver
Du T, Luo L, Gao L, Lv J. Global Prevalence of Clinically Significant Insomnia Among Cancer Patients: A Systematic Review and Meta‐Analysis. Brain and Behavior. 2026;16(11). doi:10.1002/brb3.71857
BibTeX
@article{Du2026,
author = {Du, Ting and Luo, Linyu and Gao, Langli and Lv, Juan},
title = {Global Prevalence of Clinically Significant Insomnia Among Cancer Patients: A Systematic Review and Meta‐Analysis},
journal = {Brain and Behavior},
year = {2026},
volume = {16},
number = {11},
doi = {10.1002/brb3.71857}
}
EUVIMED